Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

India · Delayed Price · Currency is INR

116.20

+0.31 (0.27%)

Oct 1, 2026, 3:29 PM IST

Market Cap	2.41B -2.4%
Revenue (ttm)	572.54M +14.1%
Net Income	1.49M -77.4%
EPS	0.07 -76.7%
Shares Out	20.80M
PE Ratio	1,611.33
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,854
Open	116.60
Previous Close	115.89
Day's Range	114.65 - 116.60
52-Week Range	97.59 - 147.00
Beta	0.49
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About NSE:LOTUSEYE

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch-free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery t... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1989

Employees 402

Stock Exchange National Stock Exchange of India

Ticker Symbol LOTUSEYE

Full Company Profile

Financial Performance

In fiscal year 2026, NSE:LOTUSEYE's revenue was 537.14 million, an increase of 8.38% compared to the previous year's 495.63 million. Earnings were 804,000, a decrease of -89.12%.

Financial Statements